BRIEF-Boston Scientific Corp Expects FY EPS On A GAAP Basis In A Range Of $1.43 To $1.48

Reuters04-24

April 24 (Reuters) - Axonics Inc :

* SEES FY EPS ON A GAAP BASIS IN A RANGE OF $1.43 TO $1.48

* SEES FY ADJUSTED EPS, EXCLUDING CERTAIN CHARGES (CREDITS), OF $2.29 TO $2.34

* SEES NET SALES GROWTH FOR FY 2024, TO BE IN RANGE OF APPROXIMATELY 11 TO 13 PERCENT ON A REPORTED BASIS

* SEES FY NET SALES GROWTH FOR FULL YEAR 2024, TO BE IN RANGE OF 10 TO 12 PERCENT ON AN ORGANIC BASIS

* SEES NET SALES GROWTH FOR Q2 OF 2024, TO BE IN A RANGE OF ABOUT 10.5 TO 12.5 PERCENT ON A REPORTED BASIS

* SEES Q2 EPS ON A GAAP BASIS IN A RANGE OF $0.35 TO $0.37 AND ADJUSTED EPS, OF $0.57 TO $0.59

((Reuters.Briefs@thomsonreuters.com;;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2429453672?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-04-24 20:55","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2429453672","market":"us","top_or_hot":-1,"title":"BRIEF-Boston Scientific Corp Expects FY EPS On A GAAP Basis In A Range Of $1.43 To $1.48","media":"Reuters","content":"<html><body><p>April 24 (Reuters) - Axonics Inc   :</p><p>   * SEES FY EPS ON A GAAP BASIS IN A RANGE OF $1.43 TO $1.48</p><p>   * SEES FY ADJUSTED EPS, EXCLUDING CERTAIN CHARGES (CREDITS), OF $2.29 TO $2.34</p><p>   * SEES NET SALES GROWTH FOR FY 2024, TO BE IN RANGE OF APPROXIMATELY 11 TO 13 PERCENT ON A REPORTED BASIS</p><p>   * SEES FY  NET SALES GROWTH FOR FULL YEAR 2024, TO BE IN RANGE OF 10 TO 12 PERCENT ON AN ORGANIC BASIS</p><p>   * SEES NET SALES GROWTH FOR Q2 OF 2024, TO BE IN A RANGE OF ABOUT 10.5 TO 12.5 PERCENT ON A REPORTED BASIS</p><p>   * SEES Q2 EPS ON A GAAP BASIS IN A RANGE OF $0.35 TO $0.37 AND ADJUSTED EPS, OF $0.57 TO $0.59</p><p>((Reuters.Briefs@thomsonreuters.com;;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Boston Scientific Corp Expects FY EPS On A GAAP Basis In A Range Of $1.43 To $1.48</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Boston Scientific Corp Expects FY EPS On A GAAP Basis In A Range Of $1.43 To $1.48\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-04-24 20:55 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>April 24 (Reuters) - Axonics Inc   :   * SEES FY EPS ON A GAAP BASIS IN A RANGE OF $1.43 TO $1.48   * SEES FY ADJUSTED EPS, EXCLUDING CERTAIN CHARGES (CREDITS), OF $2.29 TO $2.34   * SEES NET SALES ...</p>\n\n<a href=\"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BSX","symbol_name":"波士顿科学","start_time":0,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","article_id":"2429453672","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2429453672","pubTimestamp":1713963305,"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"April 24  - Axonics Inc   :   * SEES FY EPS ON A GAAP BASIS IN A RANGE OF $1.43 TO $1.48   * SEES FY ADJUSTED EPS, EXCLUDING CERTAIN CHARGES , OF $2.29 TO $2.34   * SEES NET SALES GROWTH FOR FY 2024, TO BE IN RANGE OF APPROXIMATELY 11 TO 13 PERCENT ON A REPORTED BASIS   * SEES FY  NET SALES GROWTH FOR FULL YEAR 2024, TO BE IN RANGE OF 10 TO 12 PERCENT ON AN ORGANIC BASIS   * SEES NET SALES GROWTH FOR Q2 OF 2024, TO BE IN A RANGE OF ABOUT 10.5 TO 12.5 PERCENT ON A REPORTED BASIS   * SEES Q2 EPS ON A GAAP BASIS IN A RANGE OF $0.35 TO $0.37 AND ADJUSTED EPS, OF $0.57 TO $0.59","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"BSX":"波士顿科学","AXNX":"Axonics Inc."},"translate_title":"Boston Scientific Corp预计按GAAP计算的财年每股收益在1.43美元至1.48美元之间","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BSX":1,"AXNX":0.9},"content_text":"April 24 (Reuters) - Axonics Inc   :   * SEES FY EPS ON A GAAP BASIS IN A RANGE OF $1.43 TO $1.48   * SEES FY ADJUSTED EPS, EXCLUDING CERTAIN CHARGES (CREDITS), OF $2.29 TO $2.34   * SEES NET SALES GROWTH FOR FY 2024, TO BE IN RANGE OF APPROXIMATELY 11 TO 13 PERCENT ON A REPORTED BASIS   * SEES FY  NET SALES GROWTH FOR FULL YEAR 2024, TO BE IN RANGE OF 10 TO 12 PERCENT ON AN ORGANIC BASIS   * SEES NET SALES GROWTH FOR Q2 OF 2024, TO BE IN A RANGE OF ABOUT 10.5 TO 12.5 PERCENT ON A REPORTED BASIS   * SEES Q2 EPS ON A GAAP BASIS IN A RANGE OF $0.35 TO $0.37 AND ADJUSTED EPS, OF $0.57 TO $0.59((Reuters.Briefs@thomsonreuters.com;;))","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2429453672"}